AbbVie Inc.

4AB.F·Frankfurt·Healthcare
Compare
256.20+2.10 (+0.83%)today
As of Oct 20, 3:47 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close254.10
Open254.20
Day range254.20256.20
52-week range167.55259.60
Off day high0.00%
Off 52-week high−1.31%
Volume56.00
Avg. volume (3M)66.00
Market cap452.74B
EPS (TTM)3.03
Forward P/E18.34
P/E ratio (TTM)84.55
Dividend yield2.43% (6.16)
Beta (5Y)0.23
Shares outstanding1.77B
Short interest—
Earnings dateOct 30, 2026
Analyst target—
Profit margin9.80%

Against its peers

Compare in full ›
4AB.F BMY PFE AZN JNJ.DE AMGN
Market cap 452.74B 125.99B 171.62B 261.82B 557.29B 237.31B
P/E (TTM) 84.6 13.6 39.6 25.2 40.8 27.3
Forward P/E 18.3 9.3 10.4 14.9 — 17.9
Price/book -85.6 5.6 2.0 5.2 7.4 20.3
Dividend yield 2.43% 4.09% 5.71% 1.95% 2.12% 2.30%
1-year change +27.95% +38.48% +21.80% +1.17% +35.34% +45.76%
Today +0.83% +4.84% +2.28% +2.97% +2.89% +3.29%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All 4AB.F news ›
The Globe and Mail·Positive

AbbVie's Neuroscience Franchise: What to Expect Ahead of Q3 Results

The Zacks Consensus Estimate for AbbVie’s neuroscience revenues in the third quarter of 2026 is pegged at $3.29 billion. The figure implies year-over-year growth of nearly 16%, with growth expected across most marketed products. Turning to…

From articles in the 4Search news index.

In the news

201mentions in 30 days
201with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.